Showing results (161-170 of 197) with videos related to
Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|June 9, 2015
Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalitiesBihiyga Salhi, Christel Haenebalcke, Silvia Perez-Bogerd, et al.The Lancet. Oncology|February 1, 2014
Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trialsEfstathios Zikos, Irina Ghislain, Corneel Coens, et al.The Lancet. Oncology|October 20, 2019
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trialGiovanni L Ceresoli, Joachim G Aerts, Rafal Dziadziuszko, et al.European Journal of Cancer (Oxford, England : 1990)|June 21, 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapyGijsbert W P M Kramer, Catherine L Legrand, Paul van Schil, et al.Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Improving the specificity of fluorescence bronchoscopy for the analysis of neoplastic lesions of the bronchial tree by combination with optical spectroscopy: preliminary communicationMartin P L Bard, Arjen Amelink, Marina Skurichina, et al.Plos One|June 11, 2021
Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapyMargot Geens, Sofie Stappers, Heleen Konings, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923Andrea Ardizzoni, Vivianne C G Tjan-Heijnen, Pieter E Postmus, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2016
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for MesotheliomaValerie W Rusch, Kari Chansky, Hedy L Kindler, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2008
Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access ProgramPaul Taylor, Bruno Castagneto, Graham Dark, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancerLuis Paz-Ares, Beatrix Bálint, Richard H de Boer, et al.Pageof 20